LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Omnicell Inc

Fermé

SecteurSoins de santé

38.59 3.43

Résumé

Variation du prix de l'action

24h

Actuel

Min

36.64

Max

38.84

Chiffres clés

By Trading Economics

Revenu

-7.5M

-2M

Ventes

3.4M

314M

P/E

Moyenne du Secteur

912.5

121.746

BPA

0.51

Marge bénéficiaire

-0.645

Employés

3,600

EBITDA

-10M

21M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+59.45% upside

Dividendes

By Dow Jones

Prochains Résultats

5 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-560M

1.7B

Ouverture précédente

35.16

Clôture précédente

38.59

Sentiment de l'Actualité

By Acuity

50%

50%

165 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Omnicell Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 févr. 2026, 23:44 UTC

Actions en Tendance

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 févr. 2026, 23:20 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 févr. 2026, 22:57 UTC

Résultats

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 21:59 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 févr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 févr. 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 févr. 2026, 23:19 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 23:15 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:58 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 févr. 2026, 22:58 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 févr. 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 févr. 2026, 22:50 UTC

Acquisitions, Fusions, Rachats

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 févr. 2026, 22:44 UTC

Résultats

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:42 UTC

Résultats

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 22:36 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 févr. 2026, 22:36 UTC

Résultats

Santos Final Dividend 10.3 U.S. Cents/Security

17 févr. 2026, 22:36 UTC

Résultats

Santos FY Underlying Profit US$898 Million, Down 25%

17 févr. 2026, 22:35 UTC

Résultats

Santos FY Revenue US$4.94 Billion, Down 8%

17 févr. 2026, 22:35 UTC

Résultats

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 févr. 2026, 22:35 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 févr. 2026, 22:34 UTC

Résultats

Santos FY Net Profit US$818 Billion, Down 33%

17 févr. 2026, 22:02 UTC

Acquisitions, Fusions, Rachats

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 févr. 2026, 21:50 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 févr. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Comparaison

Variation de prix

Omnicell Inc prévision

Objectif de Prix

By TipRanks

59.45% hausse

Prévisions sur 12 Mois

Moyen 58.2 USD  59.45%

Haut 70 USD

Bas 49 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

24.23 / 30.44Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

165 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat